Building better partnerships between industry & the NHS, & across the life sciences sector
Â鶹ÉçPatient Advisory Council
Council members provide the Association’s Board and its senior team with meaningful insights into the patient experience, to inform strategy, policy priorities and work.
NHS-Industry Partnership Case Studies Repository
Explore examples of how collaboration and partnership can support delivery of NHS priorities and enable the ‘triple win’ - of improved patient outcomes, more efficient use of NHS resources and evidence of impact for industry – as well as replication and scaling across the NHS.
NHS engagement
The NHS Confederation and the Â鶹Éçhave created new guidance on how to create effective NHS-industry partnerships. It was created with the expertise of more than 30 NHS and industry leaders.
The Â鶹Éçhas produced this sourcebook to support pharmaceutical companies, patients and patient organisations work together successfully, with relationships that are in the interests of patients and meet the standards set out in the 2021 Â鶹ÉçCode of Practice.
Working with patient organisations
Our ambition is to put patients at the heart of what we do, developing and delivering medicines which can have the most impact on people’s health and wellbeing. Â鶹Éçis committed to embedding system-wide patient and public involvement across the life sciences research sector.
Patient & public involvement
Our strategy sets out how the Â鶹Éçwill deliver our commitments and make sure that patient engagement is consistently at the heart of our work.
Involving the public and patients as equal partners in the discovery and development of medicines is vital. The Â鶹Éçworks with patient organisations and our members to improve how this is done.
Academic collaboration
A quarter of a million people are employed in the UK’s life science sector today. We need a continuous supply of specialists to stay competitive, meet the demands of an evolving, technology-based world and pioneer the next wave of medicines and vaccines.
The UK is recognised worldwide as a leader in medical research and innovation, and the foundations for collaborations between industry and academia in the UK are exceptionally strong.